GLOFITAMAB for B-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 95 adverse event reports in the FDA FAERS database where GLOFITAMAB was used for B-cell lymphoma.
Most Reported Side Effects for GLOFITAMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 415 | 37.2% | 102 | 239 |
| Disease progression | 183 | 16.4% | 78 | 39 |
| Off label use | 129 | 11.6% | 37 | 44 |
| Death | 125 | 11.2% | 125 | 12 |
| Neutropenia | 109 | 9.8% | 18 | 59 |
| Pyrexia | 78 | 7.0% | 15 | 46 |
| Febrile neutropenia | 69 | 6.2% | 2 | 55 |
| Covid-19 | 62 | 5.6% | 11 | 31 |
| Drug ineffective | 53 | 4.8% | 10 | 10 |
| Immune effector cell-associated neurotoxicity syndrome | 45 | 4.0% | 17 | 16 |
| Infection | 44 | 3.9% | 28 | 12 |
| Pneumonia | 41 | 3.7% | 11 | 20 |
| Sepsis | 29 | 2.6% | 15 | 14 |
| Septic shock | 27 | 2.4% | 20 | 15 |
| Alanine aminotransferase increased | 26 | 2.3% | 2 | 15 |
Other Indications for GLOFITAMAB
Diffuse large b-cell lymphoma (535)
Product used for unknown indication (107)
Mantle cell lymphoma (60)
Diffuse large b-cell lymphoma refractory (55)
Non-hodgkin's lymphoma (44)
Diffuse large b-cell lymphoma stage iv (38)
Follicular lymphoma (29)
B-cell lymphoma refractory (27)
Richter's syndrome (24)
Lymphoma transformation (19)
Other Drugs Used for B-cell lymphoma
RITUXIMAB (7,811)
CYCLOPHOSPHAMIDE (4,766)
VINCRISTINE (4,346)
DOXORUBICIN (3,947)
LENALIDOMIDE (3,474)
PREDNISONE (2,561)
BENDAMUSTINE (1,668)
PREDNISOLONE (1,489)
ETOPOSIDE (1,268)
IDELALISIB (1,240)